Current evaluation and management of patients with chronic rhinosinusitis and nasal polyps

References

• Hastan D, Fokkens WJ, Bachert CN, et al. Chronic rhinosinusitis in Europe–an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216–1223.
   PubMed Web of Science ®Google Scholar
• Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S adults: national health interview survey, 2008. Vital Heal Stat Ser 10 Data from Natl Heal Surv. 2009
   Google Scholar
• Caulley L, Thavorn K, Rudmik L, et al. Direct costs of adult chronic rhinosinusitis by using 4 methods of estimation: results of the US medical expenditure panel survey. J Allergy Clin Immunol. 2015;136(6):1517–1522.
   PubMed Web of Science ®Google Scholar
• Line S. CADTH common drug review version: final CADTH DRUG REIMBURSEMENT REVIEW pharmacoeconomic report DUPILUMAB (DUPIXENT). 2020.
   Google Scholar
• Thamboo A, Kilty S, Witterick I, et al. Canadian rhinology working group consensus statement: biologic therapies for chronic rhinosinusitis. J Otolaryngol - Head Neck Surg. 2021;50(1). DOI:10.1186/s40463-021-00493-2.
   Web of Science ®Google Scholar
• Benjamin MR, Stevens WW, Li N, et al. Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting. J Allergy Clin Immunol Pract. 2019;7(3):1010–1016.
   PubMed Web of Science ®Google Scholar
• Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA 2LEN survey in Europe. Allergy Eur J Allergy Clin Immunol. 2012;67(1):91–98.
   Google Scholar
• Laidlaw TM, Mullol J, Woessner KM, et al. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141.
   PubMed Web of Science ®Google Scholar
• Ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109(4):621–626.
   PubMed Web of Science ®Google Scholar
• Bassiouni A, Wormald PJ. Role of frontal sinus surgery in nasal polyp recurrence. Laryngoscope. 2013;123(1):36–41.
   PubMed Web of Science ®Google Scholar
• Calus L, Van Bruaene N, Bosteels C, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy. 2019;9(1). DOI:10.1186/s13601-019-0269-4.
   PubMedGoogle Scholar
• Stevens WW, Peters AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2017;5(4):1061–1070.e3.
   PubMed Web of Science ®Google Scholar
• Klossek JM, Neukirch F, Pribil C, et al. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy. 2005;60(2):233–237.
   PubMed Web of Science ®Google Scholar
• Larsen K. The clinical relationship of nasal polyps to asthma. Allery and Asthma. 1996;17(5):243–249 .
   Web of Science ®Google Scholar
• Håkansson K, Bachert C, Konge L, et al. Airway inflammation in chronic rhinosinusitis with nasal polyps and asthma: the united airways concept further supported. PLoS One. 2015;10(7):e0127228.
   PubMed Web of Science ®Google Scholar
• Mullol J, Laidlaw TM, Bachert C, et al. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: results from two randomized placebo-controlled phase 3 trials. Allergy Eur J Allergy Clin Immunol. 2022;77(4):1231–1244.
   Google Scholar
• Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019.Comment: International document of concensus, endorsed by EAACI, on the management of AERD/N.Comment: International document of concensus, endorsed by EAACI, on the management of AERD/NERD patients.
   Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020.Comment: Current European guidelines on the CRS management.
   Google Scholar
• Alobid I, Cardelus S, Benítez P, et al. Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. Rhinology. 2011;49(5):519–524.
   PubMed Web of Science ®Google Scholar
• Alobid I, Benítez P, Cardelús S, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124(1):50–56.
   PubMed Web of Science ®Google Scholar
• Mullol J, Bachert C, Amin N, et al. Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2022;10(4):1086–1095.e5.
   Web of Science ®Google Scholar
• Stevens WW, Peters AT, Tan BK, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7(8):2812–2820.e3.
   PubMed Web of Science ®Google Scholar
• Staudacher AG, Peters AT, Kato A, et al. Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2020;124.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138(5):1344–1353.
   PubMed Web of Science ®Google Scholar
• Lou H, Zhang N, Bachert C, et al. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018;8(11):1218–1225.
   PubMed Web of Science ®Google Scholar
• De Benedictis FM, Del Guidice M M, Severini S, et al. Rhinitis, sinusitis and asthma: one linked airway disease. Paediatr Respir Rev. 2001;2(4):358–364.
   PubMedGoogle Scholar
• Kuo CHS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J. 2017;49(2):1602135.
   PubMed Web of Science ®Google Scholar
• Chung KF, Adcock IM. Precision medicine for the discovery of treatable mechanisms in severe asthma [Internet]. Allergy: Eur J Allergy Clin Immunol. 2019;74(9):1649–1659.
   Google Scholar
• Ricciardolo FLM, Sprio AE, Baroso A, et al. Characterization of T2-Low and T2-High asthma phenotypes in real-life. Biomedicines. 2021;9(11):1684.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Derycke L, Holtappels G, et al. Th2 cytokines orchestrate the secretion of MUC 5 AC and MUC 5B in IL −5-positive chronic rhinosinusitis with nasal polyps. Allergy Eur J Allergy Clin Immunol. 2019;74(1):131–140.
   Google Scholar
• Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–1456.e4.
   PubMed Web of Science ®Google Scholar
• Khan A, Vandeplas G, Huynh TMT, et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;57(1):32–42.
   PubMed Web of Science ®Google Scholar
• Plaza V, Alobid I, Alvarez C, et al. Spanish asthma management guidelines (GEMA) VERSION 5.1 Highlights and Controversies. Arch Bronconeumol. 2022;58(2):150–158.
   Web of Science ®Google Scholar
• Castillo J, Picado C, Plaza V, et al. IRIS-asthma study group rhinitis and chronic rhinosinusitis associated in adult asthma depending on severity of their disease. Allergy. 2013;68(Suppl 97):542–543.
   Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46(5):1308–1321.
   PubMed Web of Science ®Google Scholar
• Gevaert P, Saenz R, Corren J, et al. Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. J Allergy Clin Immunol. 2022;149(3):957–965.e3.
   Web of Science ®Google Scholar
• Bachert C, Van Steen K, Zhang N, et al. Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol. 2012;130(2):376–381.e8.
   PubMed Web of Science ®Google Scholar
• Strehl C, Ehlers L, Gaber T, et al. Glucocorticoids-all-rounders tackling the versatile players of the immune system. Front Immunol. 2019;10. DOI:10.3389/fimmu.2019.01744.
   PubMed Web of Science ®Google Scholar
• Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- And long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clinical and Translational Allergy. Clin Transl Allergy; 2020.
   Google Scholar
• Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739.
   Web of Science ®Google Scholar
• Healy DP. Macrolide immunomodulation of chronic respiratory diseases. Curr Infect Dis Rep. 2007;9(1):7–13.
   PubMedGoogle Scholar
• Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116(2):189–193.
   PubMed Web of Science ®Google Scholar
• Zeng M, Wang H, Liao B, et al. Clinical and biological markers predict the efficacy of glucocorticoid- and macrolide-based postoperative therapy in patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2021;35(5):596–606.
   PubMed Web of Science ®Google Scholar
• Haruna S, Shimada C, Ozawa M, et al. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology. 2009;47(1):66–71.
   PubMed Web of Science ®Google Scholar
• Bezerra TFP, Pezato R, de Barros PM, et al. Prospective evaluation of clarithromycin in recurrent chronic rhinosinusitis with nasal polyps. Braz J Otorhinolaryngol. 2021;87(3):298–304.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82–111.
   PubMedGoogle Scholar
• Chin D, Harvey RJ. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment. Curr Opin Otolaryngol Head Neck Surg. 2013;21(1):23–30.
   PubMed Web of Science ®Google Scholar
• Rimmer J, Fokkens W, Chong LY, et al. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;(12):CD006991.
   Google Scholar
• Sharma R, Lakhani R, Rimmer J, et al. Surgical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;(11):CD006990.
   Google Scholar
• Snidvongs K, Kalish L, Sacks R, et al. Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis. Am J Rhinol Allergy. 2013;27(3):221–233.
   PubMed Web of Science ®Google Scholar
• Bassiouni A, Ou J, Rajiv S, et al. Subepithelial inflammatory load and basement membrane thickening in refractory chronic rhinosinusitis with nasal polyposis: a histopathological study. Int Forum Allergy Rhinol. 2016;6(3):248–255.
   PubMed Web of Science ®Google Scholar
• Rudmik L, Soler ZM, Hopkins C, et al. Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Int Forum Allergy Rhinol. 2016;6(6):557–567.
   PubMed Web of Science ®Google Scholar
• Hopkins C, Andrews P, Holy CE. Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data. Rhinology. 2015;53(1):18–24.
   Web of Science ®Google Scholar
• Hopkins C, Rudmik L, Lund VJ. The predictive value of the preoperative sinonasal outcome test-22 score in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2015;125(8):1779–1784.
   PubMed Web of Science ®Google Scholar
• Benninger MS, Sindwani R, Holy CE, et al. Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization. Otolaryngol Head Neck Surg. 2015;152(3):546–552.
   PubMed Web of Science ®Google Scholar
• Deconde AS, Suh JD, Mace JC, et al. Outcomes of complete vs targeted approaches to endoscopic sinus surgery. Int Forum Allergy Rhinol. 2015;5(8):691–700.
   PubMed Web of Science ®Google Scholar
• Masterson L, Tanweer F, Bueser T, et al. Extensive endoscopic sinus surgery: does this reduce the revision rate for nasal polyposis? Eur Arch Oto-Rhino-Laryngology. 2010;267(10):1557–1561.
   PubMed Web of Science ®Google Scholar
• Jankowski R, Bodino C. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalisation of the ethmoid - Radical ethmoidectomy is functional surgery for NPS. Rhinology. 2003;41(4):211–219.
   Web of Science ®Google Scholar
• Alsharif S, Jonstam K, van Zele T, et al. Endoscopic sinus surgery for type-2 CRS wNP: an endotype-based retrospective study. Laryngoscope. 2019;129(6):1286–1292.
   PubMed Web of Science ®Google Scholar
• Abuzeid WM, Vakil M, Lin J, et al. Endoscopic modified Lothrop procedure after failure of primary endoscopic sinus surgery: a meta-analysis. Int Forum Allergy Rhinol. 2018;8(5):605–613.
   PubMed Web of Science ®Google Scholar
• Jonstam K, Alsharif S, Bogaert S, et al. Extent of inflammation in severe nasal polyposis and effect of sinus surgery on inflammation. Allergy. 2021;76(3):933–936.
   PubMed Web of Science ®Google Scholar
• Moreno-Luna R, González-García J, Maza-Solano JM, et al. Free nasal floor mucosal grafting after endoscopic total ethmoidectomy for severe nasal polyposis: a pilot study. Rhinology. 2019. DOI:10.4193/Rhin18.178.
   PubMed Web of Science ®Google Scholar
• Moreno-Luna R, González-García J, Palacios-García J, et al. Usefulness of endonasal mucoplasty in the surgical treatment of chronic rhinosinusitis with nasal polyps Prospective study. Otorrinolaringol Esp (Engl Ed). 2021;72(4):256–261.
   Web of Science ®Google Scholar
• Sahlstrand-Johnson P, Hopkins C, Ohlsson B, et al. The effect of endoscopic sinus surgery on quality of life and absenteeism in patients with chronic rhinosinuitis - A multi-centre study. Rhinology. 2017;55(3):251–261.
   PubMed Web of Science ®Google Scholar
• Yip J, Hao W, Eskander A, et al. Wait times for endoscopic sinus surgery influence patient-reported outcome measures in patients with chronic rhinosinusitis who fulfill appropriateness criteria. Int Forum Allergy Rhinol. 2019;9(4):396–401.
   Web of Science ®Google Scholar
• Kato A, Peters AT, Stevens WW, et al. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022;77(3):812–826.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74(12):2312–2319.
   PubMed Web of Science ®Google Scholar
• Hopkins C, McKenzie JL, Anari S, et al. British rhinological society consensus guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol. 2021;46(5):1037–1043.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36.
   PubMed Web of Science ®Google Scholar
• Guntern P, Eggel A. Past, present, and future of anti-IgE biologics. Allergy: Eur J Allergy Clin Immunol. 2020;75(10):2491–2502.
   Google Scholar
• Di Bona D, Fiorino I, Taurino M, et al. Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: a nine-year study. Respir Med. 2017;130:55–60.
   PubMed Web of Science ®Google Scholar
• Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605.
   PubMed Web of Science ®Google Scholar
• Bachert C, Sousa AR, Lund VJ, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol. 2017;140(4):1024–1031.e14.
   PubMed Web of Science ®Google Scholar
• Karp J, Dhillon I, Panchmatia R, et al. Subcutaneous mepolizumab injection: an adjunctive treatment for recalcitrant allergic fungal rhinosinusitis patients with asthma. Am J Rhinol Allergy. 2021;35(2):256–263.
   PubMed Web of Science ®Google Scholar
• Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9(10):1141–1153.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Desrosiers MY, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309–1317.e12.
   Web of Science ®Google Scholar
• Mitchell P, Leigh R. A drug safety review of treating eosinophilic asthma with monoclonal antibodies. Expert Opin Drug Saf. 2019;18(12):1161–1170.
   PubMed Web of Science ®Google Scholar
• Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. J Am Med Assoc. 2016;315(5):469.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–1650.
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Mullol J, Fan C, et al. Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J Allergy Clin Immunol Pract. 2019;7(7):2462–2465.e1.
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Bachert C, Amin N, et al. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol. 2021;126(5):584–592.e1.
   PubMed Web of Science ®Google Scholar
• Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455–2466.
   PubMed Web of Science ®Google Scholar
• Vennera MDC, Picado C, Mullol J, et al. Efficacy of omalizumab in the treatment of nasal polyps. Thorax. 2011;66(9);824–825.
   Web of Science ®Google Scholar
• Tiotiu A, Oster JP, Roux PR, et al. Effectiveness of omalizumab in severe allergic asthma and nasal polyposis: a real-life study. J Investig Allergol Clin Immunol. 2020;30(1):49–57.
   PubMed Web of Science ®Google Scholar
• Harvey ES, Langton D, Katelaris C, et al. Mepolizumab effectiveness and identification of super-responders in severe asthma. Eur Respir J. 2020;55(5):1902420.
   PubMed Web of Science ®Google Scholar
• Howarth P, Chupp G, Nelsen LM, et al. Severe eosinophilic asthma with nasal polyposis: a phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy. J Allergy Clin Immunol. 2020;145(6):1713–1715.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Wechsler ME, Mark Fitzgerald J, et al. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma. Eur Respir J. 2018;52(4):1800936.
   PubMed Web of Science ®Google Scholar
• Weinstein SF, Katial RK, Bardin P, et al. Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2019;7(2):589–596.e3.
   PubMed Web of Science ®Google Scholar
• Gandhi NA, Bennett BL, Graham NMH, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35–50.
   PubMed Web of Science ®Google Scholar
• Vlastos I, Gkouskou K, Doulaptsi M, et al. Precision medicine in rhinosinusitis. Curr Allergy Asthma Rep. 2019;19(2). DOI:10.1007/s11882-019-0850-x.
   PubMed Web of Science ®Google Scholar
• Lombardi C, Passalacqua G, Asero R, et al. ARIA Italia. ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments. World Allergy Organ J. 2021;14(10):100592 .
   Web of Science ®Google Scholar
• Gance-Cleveland B, Ozkaynak M. Multidisciplinary teams are essential for developing clinical decision support to improve pediatric health outcomes: an exemplar. J Pediatr Nurs. 2021;58:104–106.
   PubMed Web of Science ®Google Scholar
• Holmes LJ, Sheehan R, Elsey L, et al. The multidisciplinary team severe asthma day case assessment and its impact on patient care. Br J Hosp Med (Lond). 2021;82(7):1–7.
   PubMed Web of Science ®Google Scholar
• Li KL, Fang CH, Ferastraoaru D, et al. Patient satisfaction and efficiency benefits of a novel multidisciplinary rhinology and allergy clinic. Ann Otol Rhinol Laryngol. 2020;129(7):699–706.
   PubMed Web of Science ®Google Scholar
• Clark VL, Gibson PG, Genn G, et al. Multidimensional assessment of severe asthma: a systematic review and meta-analysis. Respirology. 2017;22(7):1262–1275.
   PubMed Web of Science ®Google Scholar
• Peters AT, Han JK, Hellings P, et al. Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(6):2461–2471.e5.
   PubMed Web of Science ®Google Scholar
• Mullol J, Del Cuvillo A, Lockey RF. Rhinitis phenotypes. J Allergy Clin Immunol Pract. 2020;8(5):1492–1503.
   PubMed Web of Science ®Google Scholar
• Naclerio R, Baroody F, Bachert C, et al. Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics: a national institute of allergy and infectious diseases workshop. J Allergy Clin Immunol Pract. 2020;8(5):1532–1549.e1.
   PubMed Web of Science ®Google Scholar
• Nasta MS, Chatzinakis VA, Georgalas CC. Updates on current evidence for biologics in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2020;28(1):18–24.
   PubMed Web of Science ®Google Scholar